Filing Details
- Accession Number:
- 0001474506-20-000103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-16 16:44:47
- Reporting Period:
- 2020-03-12
- Accepted Time:
- 2020-03-16 16:44:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1691430 | Quanta Inc | N/A | Medicinal Chemicals & Botanical Products (2833) | 812749032 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1796869 | Blake Gillette | 3606 W Magnolia Blvd Burbank CA 91505 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-03-12 | 2,000 | $0.18 | 2,037,746 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The purchase price reported in Column 4 is a weighted average price of multiple purchases in a range of purchase prices between $0.165 per share and $0.188 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within this range.